3-[[2-(4-amino-5-iminopyrrol-3-yl)quinazolin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
C21H22N6O2 — CID 135136838
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[2-(4-amino-5-iminopyrrol-3-yl)quinazolin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid
3-[[2-(4-amino-5-iminopyrrol-3-yl)quinazolin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid (PubChem CID 135136838) has the molecular formula C21H22N6O2 and a molecular weight of 390.45 g/mol. Its IUPAC name is 3-[[2-(4-amino-5-iminopyrrol-3-yl)quinazolin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid.
Molecular Properties
| Compound Name | 3-[[2-(4-amino-5-iminopyrrol-3-yl)quinazolin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid |
|---|---|
| PubChem CID | 135136838 |
| Molecular Formula | C21H22N6O2 |
| Molecular Weight | 390.45 g/mol |
| Exact Mass | 390.18 |
| IUPAC Name | 3-[[2-(4-amino-5-iminopyrrol-3-yl)quinazolin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid |
| SMILES | [H]/N=C1\N=CC(c2nc(NC3C4CCC(CC4)C3C(=O)O)c3ccccc3n2)=C1N |
| InChI | InChI=1S/C21H22N6O2/c22-16-13(9-24-18(16)23)20-25-14-4-2-1-3-12(14)19(27-20)26-17-11-7-5-10(6-8-11)15(17)21(28)29/h1-4,9-11,15,17H,5-8H2,(H,28,29)(H3,22,23,24)(H,25,26,27) |
| InChIKey | SUVCTOPXQJLXRF-UHFFFAOYSA-N |
| XLogP | 2.66 |
| TPSA | 137.34 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 390.45 |
| LogP ≤ 5 | 2.66 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135136838 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.